-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HCV-IN-3
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/1401839-25-5.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 1401839-25-5 |
| Description | HCV-IN-3 is an inhibitor of hepatitis C virus (HCV) NS3/4a protein, with an IC50 of 20 μM and a Kd of 29 μM. |
Product Information
| Synonyms | 2,4-Difluoro-3-phenoxybenzenemethaneamine; Benzenemethanamine, 2,4-difluoro-3-phenoxy-; 1-(2,4-Difluoro-3-phenoxyphenyl)methanamine |
| IUPAC Name | (2,4-difluoro-3-phenoxyphenyl)methanamine |
| Molecular Weight | 235.23 |
| Molecular Formula | C13H11F2NO |
| Canonical SMILES | C1=CC=C(C=C1)OC2=C(C=CC(=C2F)CN)F |
| InChI | InChI=1S/C13H11F2NO/c14-11-7-6-9(8-16)12(15)13(11)17-10-4-2-1-3-5-10/h1-7H,8,16H2 |
| InChIKey | OPHNCLQYKIKHON-UHFFFAOYSA-N |
| Boiling Point | 279.9±40.0°C at 760 mmHg |
| Purity | ≥95% |
| Density | 1.2±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 234 |
| Exact Mass | 235.08087030 |
| Target | IC50: 20 μM (HCVNS3), Kd: 29 μM (HCVNS3) |
| XLogP3-AA | 2.5 |